Download in electronic PDF format for $25

Kalchem International - Chemicals and Compounding Supplies

Search the Complete Journal Archives

Stability of Ursodiol in SyrSpend SF Cherry Flavored

Author(s):  Geiger Christine M, Voudrie Mark A II, Sorenson Bridget

Issue:  Nov/Dec 2012 - Volume 16, Number 6
View All Articles in Issue

Note:  Electronic version includes errata or revisions.

Abstract:  Ursodiol is used in the treatment and prevention of certain types of gallstones and for patients with primary biliary cirrhosis. Ursodiol is marketed for this purpose by Watson Pharma, Inc. as ACTIGALL, by Axcan Scandipharm Inc. as URSO 250 and URSO Forte, and by a number of generic manufacturers. Ursodiol is available as capsules of varying strengths. The need for other dose-form options for those patients who cannot take capsules has led compounding pharmacies to seek other alternatives, namely oral solutions and suspensions. Additionally, some patients are unable to tolerate suspending agents containing alcohol or sorbitol. The objective of this study was to determine the stability of ursodiol in SyrSpend SF Cherry Flavored which does not contain sorbitol or alcohol. The studied sample was compounded into a 30-mcg/mL suspension and stored in a low-actinic plastic bottle at temperatures between 2°C and 8°C. Six samples were assayed at each time point out to 66 days by a stability-indicating high-performance liquid chromatography method. The method was validated for its specificity through forced degradation studies. The sample remained within 90% to 110% of the initial concentration throughout the course of the study. The beyond-use date of this product is at least 66 days, based on data collected when refrigerated and protected from light.

Related Keywords: Christine M. Geiger, MS, Mark A. Voudrie II, MS, PMP, Bridget Sorenson, BS, CAPM, ursodiol, bile acid, gallstones, cholelithiasis, oral suspension, stability

Related Categories: EXCIPIENTS, GASTROENTEROLOGY, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, DOSAGE FORMS/DRUG CARRIERS, STORAGE

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Stability of Ursodiol in SyrSpend SF Cherry Flavored Geiger Christine M, Voudrie Mark A II, Sorenson Bridget Nov/Dec 2012 510-512 Buy
Stability of Propranolol Hydrochloride in SyrSpend SF Geiger Christine M, Voudrie Mark A II, Sorenson Bridget Nov/Dec 2012 513-515 Buy
Stability of Gabapentin in SyrSpend SF Sorenson Bridget, Voudrie Mark A II, Gehrig Dan Jul/Aug 2012 347-349 Buy
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) Whaley Paul A, Voudrie Mark A II, Sorenson Bridget Mar/Apr 2012 164-166 Buy
Stability of Captopril in SyrSPend SF Geiger Christine M, Sorenson Bridget, Whaley Paul A Jul/Aug 2013 336-338 Buy
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry Geiger Christine M, Sorenson Bridget, Whaley Paul A Jul/Aug 2013 344-346 Buy
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles Voudrie Mark A, Alexander Bridget, Allen D Brett May/Jun 2011 255-258 Buy
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Geiger Christine M, Sorenson Bridget, Whaley Paul Sep/Oct 2015 420-427 Buy
Stability of Minoxidil in Espumil Foam Base Geiger Christine M, Sorenson Bridget, Whaley Paul A Mar/Apr 2013 165-167 Buy
Stability of Vancomycin in SyrSpend SF Whaley Paul A, Voudrie Mark A II Mar/Apr 2012 167-169 Buy